Paietta EM - Search Results

1

Incidence of therapy-related myeloid neoplasia after initial therapy for chronic lymphocytic leukemia with fludarabine-cyclophosphamide versus fludarabine: long-term follow-up of US Intergroup Study E2997.

Smith MR, Neuberg D, Flinn IW, Grever MR, Lazarus HM, Rowe JM, Dewald G, Bennett JM, Paietta EM, Byrd JC, Hussein MA, Appelbaum FR, Larson RA, Litzow MR, Tallman MS. Smith MR, et al. Among authors: paietta em. Blood. 2011 Sep 29;118(13):3525-7. doi: 10.1182/blood-2011-03-342485. Epub 2011 Jul 29. Blood. 2011. PMID: 21803850 Free PMC article. Clinical Trial.

2

Phase II study of mitoxantrone and 5-azacytidine for accelerated and blast crisis of chronic myelogenous leukemia: a study of the Eastern Cooperative Oncology Group.

Dutcher JP, Eudey L, Wiernik PH, Paietta E, Bennett JM, Arlin Z, Kellermeyer R, Rowe J, O'Connell M, Oken M, et al. Dutcher JP, et al. Leukemia. 1992 Aug;6(8):770-5. Leukemia. 1992. PMID: 1379312 Clinical Trial.

3

Escalating the intensity of post-remission therapy improves the outcome in acute myeloid leukemia: the ECOG experience. The Eastern Cooperative Oncology Group.

Cassileth PA, Andersen JW, Bennett JM, Harrington DP, Hines JD, Lazarus HM, Mazza JJ, McGlave PP, O'Connell MJ, Paietta E, et al. Cassileth PA, et al. Leukemia. 1992;6 Suppl 2:116-9. Leukemia. 1992. PMID: 1578910 Clinical Trial.

4

Adult acute lymphocytic leukemia: the Eastern Cooperative Oncology Group experience.

Cassileth PA, Andersen JW, Bennett JM, Hoagland HC, Mazza JJ, O'Connell MC, Paietta E, Wiernik P. Cassileth PA, et al. Leukemia. 1992;6 Suppl 2:178-81. Leukemia. 1992. PMID: 1578927 Clinical Trial. No abstract available.

5

A randomized placebo-controlled phase III study of granulocyte-macrophage colony-stimulating factor in adult patients (> 55 to 70 years of age) with acute myelogenous leukemia: a study of the Eastern Cooperative Oncology Group (E1490).

Rowe JM, Andersen JW, Mazza JJ, Bennett JM, Paietta E, Hayes FA, Oette D, Cassileth PA, Stadtmauer EA, Wiernik PH. Rowe JM, et al. Blood. 1995 Jul 15;86(2):457-62. Blood. 1995. PMID: 7605984 Free article. Clinical Trial.

6

Characterization of acute promyelocytic leukemia cases with PML-RAR alpha break/fusion sites in PML exon 6: identification of a subgroup with decreased in vitro responsiveness to all-trans retinoic acid.

Gallagher RE, Li YP, Rao S, Paietta E, Andersen J, Etkind P, Bennett JM, Tallman MS, Wiernik PH. Gallagher RE, et al. Blood. 1995 Aug 15;86(4):1540-7. Blood. 1995. PMID: 7632962 Free article.

7

The immunophenotype of acute promyelocytic leukemia (APL): an ECOG study.

Paietta E, Andersen J, Gallagher R, Bennett J, Yunis J, Cassileth P, Rowe J, Wiernik PH. Paietta E, et al. Leukemia. 1994 Jul;8(7):1108-12. Leukemia. 1994. PMID: 8035602

8

Acute myeloid leukemia M4 with inv(16) (p13q22) exhibits a specific immunophenotype with CD2 expression.

Paietta E, Wiernik PH, Andersen J, Bennett J, Yunis J. Paietta E, et al. Blood. 1993 Oct 15;82(8):2595. Blood. 1993. PMID: 8104541 Free article. No abstract available.

9

Acute leukemia with t(10;11)(p11-p15;q13-q23).

Secco C, Wiernik PH, Bennett JM, Paietta E. Secco C, et al. Cancer Genet Cytogenet. 1996 Jan;86(1):31-4. doi: 10.1016/0165-4608(95)00165-4. Cancer Genet Cytogenet. 1996. PMID: 8616782

10

Morphologic classification of acute myeloid leukemia: concordance among Eastern Cooperative Oncology Group investigators: a comment.

Bennett JM, Cassileth PA, Paietta E, Rowe JM, Wiernik PH. Bennett JM, et al. Leukemia. 1996 Aug;10(8):1365. Leukemia. 1996. PMID: 8709645 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

314 results

Search Page

Filters